AnandRathi

Beta Drugs Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
2,194.20
-66.80 (-2.95%)

Beta Drugs Ltd (Beta Drugs Ltd) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹2,432 crore.

Beta Drugs Ltd Overview

Market cap₹2,432 Crs
Volume26,249
Prev. Close₹2,261.00
Year range₹990.10 - ₹2,807.90
Total Value₹5,75,95,555.80
ISININE351Y01019

Beta Drugs Ltd Fundamental Analysis

ROCE(TTM)10.56%
P/E Ratio (TTM)151.74
P/B Ratio16.16
Debt to Equity0.87
ROE9.58%
EPS (TTM)14.46
Dividend Yield0.00%
Book Value135.76
Profit Margin7.45%
Operating Margin9.81%

Beta Drugs Ltd Historical Performance

1 Month Return-1.64%
6 Month Return108.65%
3 Year Return127.66%
3 Month Return52.16%
1 Year Return16.03%
5 Year Return558.27%

Beta Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research